STANISLAS cohort follow-up visit for heart and kidney health
Treatments studied
Part of Heart & circulation clinical trials.
This study is a follow-up visit for people who joined the STANISLAS family health cohort. Researchers look at how genes and environment may affect heart and kidney (kidneys) health over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 years
- You previously took part in the STANISLAS Cohort
- You are covered by a French social security plan (or are a beneficiary)
- You were fully told about the study and agreed by signing consent
- You are not pregnant, giving birth, or breastfeeding at the time of the visit
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how genetic markers (DNA) relate to heart health and “metabolic” health (how your body manages sugar and fat). You may be asked to provide genetic samples and follow study health checks and protocols to help researchers understand who is at higher risk.
This study looks at how your daily habits—like what you eat, how much you exercise, and your sleep—relate to your heart health. Researchers will ask you to fill out a questionnaire and collect information from your medical records to learn more.
This study follows working adults over time to learn how lifestyle and physical fitness affect long-term health. If you join, you'll help researchers understand how to prevent heart disease and other conditions.
This study follows young adults who previously joined the ALSPAC study to better understand long-term heart and metabolic health after a pregnancy affected by high blood pressure. You may be asked to return for visits and possibly an MRI, and your data may help researchers plan better long-term care.
This study looks at blood markers (“biomarkers”) to better understand health risk in older adults who have multiple long-term illnesses and are taking statin medicines. It may help researchers predict outcomes and improve care for people with complex health needs.
This study creates a registry to track people who have early signs of heart, kidney, liver, or metabolic health issues. It aims to better understand these conditions and find ways to prevent them from getting worse.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.